Thank Otezla for Amgen's Q3 Revenue and Earnings Beats

Thank Otezla for Amgen's Q3 Revenue and Earnings Beats

Without the purchase of the blockbuster autoimmune disease drug, Amgen's latest results wouldn't have looked nearly as good.